凤凰网首页 手机凤凰网

凤凰卫视
  • [亚太] 上证指数 2319.12 (1.00%) 深证成指 9466.14 1.78% 恒生指数 19664.10 -1.06% 台北 7233.69 0.17% 韩国 1964.83 0.39%
  • [亚太] 日经 8841.22 -0.09% 澳大利亚 4348.48 0.45% 新西兰 3294.64 0.40% 印度孟买 17234.00 0.92% 新加坡 2916.26 0.75%
  • [美洲] 道琼斯 12660.50 -0.58% 纳斯达克 2816.55 0.40% 标普500 1316.33 -0.16% 加拿大 12466.50 0.02% 巴西 62904.20 -0.08%
  • [欧洲] 英国富时 5733.45 -1.07% 法国CAC 3318.76 -1.32% 德国DAX 6511.98 -0.43% 俄罗斯 1508.04 -0.44% Stoxx50 2436.62 -0.97%
  • [其他] 纽约原油 99.70 0.00% 纽约黄金 1738.40 0.00% 人民币/美元 6.33 0.00% 美元指数 78.83 0.00% 基金指数 3782.30 1.37%
  • [亚太] 上证指数 2319.12 (1.00%) 深证成指 9466.14 1.78% 恒生指数 19664.10 -1.06% 台北 7233.69 0.17% 韩国 1964.83 0.39%
  • [亚太] 日经 8841.22 -0.09% 澳大利亚 4348.48 0.45% 新西兰 3294.64 0.40% 印度孟买 17234.00 0.92% 新加坡 2916.26 0.75%
  • [美洲] 道琼斯 12660.50 -0.58% 纳斯达克 2816.55 0.40% 标普500 1316.33 -0.16% 加拿大 12466.50 0.02% 巴西 62904.20 -0.08%
  • [欧洲] 英国富时 5733.45 -1.07% 法国CAC 3318.76 -1.32% 德国DAX 6511.98 -0.43% 俄罗斯 1508.04 -0.44% Stoxx50 2436.62 -0.97%
  • [其他] 纽约原油 99.70 0.00% 纽约黄金 1738.40 0.00% 人民币/美元 6.33 0.00% 美元指数 78.83 0.00% 基金指数 3782.30 1.37%
免费注册
梅花生物(600873)公告正文

梅花生物:2017年第一季度报告

公告日期 2017-04-20
股票简称:梅花生物 股票代码:600873
                   2017 年第一季度报告



公司代码:600873                         公司简称:梅花生物




 梅花生物科技集团股份有限公司
     2017 年第一季度报告




                         1 / 17
                                 2017 年第一季度报告




                                      目录
一、重要提示...................................................................... 3

二、公司基本情况.................................................................. 3

三、重要事项...................................................................... 5

四、附录   ...................................................................... 7




                                       2 / 17
                                           2017 年第一季度报告



一、 重要提示

1.1 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整,
    不存在虚假记载、误导性陈述或者重大遗漏,并承担个别和连带的法律责任。

1.2 公司全体董事出席董事会审议季度报告。

1.3 公司负责人孟庆山、主管会计工作负责人李勇刚及会计机构负责人(会计主管人员)王爱玲
    保证季度报告中财务报表的真实、准确、完整。

1.4 本公司第一季度报告未经审计。

二、 公司基本情况

2.1 主要财务数据

                                                                                    单位:元 币种:人民币
                                                                                          本报告期末比上年度末
                                     本报告期末                    上年度末
                                                                                                 增减(%)
总资产                              16,809,158,078.16               16,983,012,102.37                        -1.02
归属于上市公司股东的净资产           9,405,425,370.16                9,064,019,058.49                         3.77
                                年初至报告期末               上年初至上年报告期末          比上年同期增减(%)
经营活动产生的现金流量净额            305,550,291.38                  332,471,348.53                         -8.10
                                年初至报告期末               上年初至上年报告期末         比上年同期增减(%)
营业收入                             2,739,108,531.41                2,643,193,726.17                         3.63
归属于上市公司股东的净利润            341,433,631.67                  221,744,194.40                         53.98
归属于上市公司股东的扣除非
                                      284,100,338.50                  200,747,699.15                         41.52
经常性损益的净利润
加权平均净资产收益率(%)                         3.70                           2.63       增加 1.07 个百分点
基本每股收益(元/股)                             0.11                           0.07                        57.14
稀释每股收益(元/股)                             0.11                           0.07                        57.14


非经常性损益项目和金额
√适用 □不适用
                                                                                    单位:元 币种:人民币
                             项目                                               本期金额                   说明
非流动资产处置损益                                                                      -219,199.46
计入当期损益的政府补助,但与公司正常经营业务密切相关,符合国
                                                                                     54,938,909.19
家政策规定、按照一定标准定额或定量持续享受的政府补助除外
除同公司正常经营业务相关的有效套期保值业务外,持有交易性金融
资产、交易性金融负债产生的公允价值变动损益,以及处置交易性金                         13,856,097.95
融资产、交易性金融负债和可供出售金融资产取得的投资收益
除上述各项之外的其他营业外收入和支出                                                 -2,511,484.27
少数股东权益影响额(税后)                                                              -180,942.61
所得税影响额                                                                         -8,550,087.63
                             合计                                                    57,333,293.17




                                                    3 / 17
                                          2017 年第一季度报告



2.2 截止报告期末的股东总数、前十名股东、前十名流通股东(或无限售条件股东)持股情况表

                                                                                                        单位:股
股东总数(户)                                                                                              162,009
                                            前十名股东持股情况
                            期末持股        比例      持有有限售条           质押或冻结情况
    股东名称(全称)                                                                                      股东性质
                              数量          (%)       件股份数量          股份状态           数量
孟庆山                      854,103,033     27.48                  0           质押         423720000    境内自然人
胡继军                      248,469,341      7.99                  0             无                      境内自然人
杨维永                       78,810,526      2.54                  0             无                      境内自然人
王爱军                       71,316,274      2.29                  0             无                      境内自然人
梁宇博                       53,668,518      1.73                  0             无                      境内自然人
香港鼎晖生物科技有限公司     40,125,120      1.29                  0           未知                        境外法人
梅花生物科技集团股份有限
公司-2017 年第一期员工      29,007,028      0.93                  0             无                             其他
持股计划
创金合信基金-浦发银行-
创金合信新活力 1 号分级型    28,831,607      0.93                  0           未知                             其他
资产管理计划
廖方红                       23,639,202      0.76                  0           未知                      境内自然人
何君                         23,449,758      0.75                  0             无                      境内自然人
                                       前十名无限售条件股东持股情况
股东名称                                  持有无限售条件流通股的数                      股份种类及数量
                                                       量                            种类                数量
孟庆山                                                      854,103,033       人民币普通股               854,103,033
胡继军                                                      248,469,341       人民币普通股               248,469,341
杨维永                                                       78,810,526       人民币普通股                78,810,526
王爱军                                                       71,316,274       人民币普通股                71,316,274
梁宇博                                                       53,668,518       人民币普通股                53,668,518
香港鼎晖生物科技有限公司                                     40,125,120       人民币普通股                40,125,120
梅花生物科技集团股份有限公司-2017 年
                                                             29,007,028       人民币普通股                29,007,028
第一期员工持股计划
创金合信基金-浦发银行-创金合信新活
                                                             28,831,607       人民币普通股                28,831,607
力 1 号分级型资产管理计划
廖方红                                                       23,639,202       人民币普通股                23,639,202
何君                                                         23,449,758       人民币普通股                23,449,758
                                          上述股东中,孟庆山、王爱军、何君为一致行动人,其他股东未知其一
上述股东关联关系或一致行动的说明
                                          致行动关系。
备注:
1.为保持信息披露的连续性和可比性,截止到报告期末的股东户数数据来源为中国登记结算有限
责任公司上海分公司发来的未合并融资融券信用账户的股东名册,公司往年定期报告亦同。
2.根据合并普通账户和融资融券信用账户的股东名册,截止 2016 年底股东总数为 190,490 户,截
止 2016 年度报告披露日前上一月末的普通股股东总数为 184,822 户,截止本报告期末股东户数为
167,890 户。


                                                   4 / 17
                                             2017 年第一季度报告



   2.3 截止报告期末的优先股股东总数、前十名优先股股东、前十名优先股无限售条件股东持股情
       况表

   □适用 √不适用

   三、 重要事项

   3.1 公司主要会计报表项目、财务指标重大变动的情况及原因

   √适用 □不适用

  资产负债表:                                                                                         单位:万元
         项目      本报告期末   上年度期末         增减额      增减幅度%                    差异说明
                                                                               主要系本期预付原辅材料款增加所
预付账款           18,066.95    11,248.33          6,818.62         60.62
                                                                               致
                                                                               本期收回处置子公司大连汉信股权
其他应收款         22,447.49    52,381.54         -29,934.04        -57.15
                                                                               转让款所致

可供出售金融资产   64,351.98    29,451.98         34,900.00         118.50     本期新增艾美股权投资所致

                                                                               主要系本期技改等项目工程款增加
在建工程           18,681.26    13,032.23          5,649.02         43.35
                                                                               所致
                                                                               主要系子公司通辽梅花购进工程物
工程物资             702.56       245.32            457.24          186.39
                                                                               资增加所致
短期借款           209,266.30   155,591.55        53,674.75         34.50      本期新增银行借款所致
应付票据            2,210.00      10.00            2,200.00        22,000.00   本期新增银行承兑汇票所致
预收款项           24,780.75    37,758.90         -12,978.15        -34.37     主要系上年末加大资金回笼所致
其他流动负债       49,964.95    149,893.99        -99,929.04        -66.67     本期短期融资券到期偿还所致
利润表:                                                                                               单位:万元
         项目      本报告期     上年同期           增减额      增减幅度%       差异说明
                                                                               本期房产税、土地使用税等税金转至
税金及附加          4,315.67      883.28           3,432.39         388.60
                                                                               税金及附加科目核算所致
投资收益            1,385.61      225.76           1,159.85         513.76     本期理财收益增加所致
营业外收入          5,892.85     2,231.68          3,661.17         164.05     本期政府补贴及其他收入增加所致
营业外支出           672.03       122.46            549.57          448.78     本期捐赠支出增加所致
所得税              5,749.57     3,311.28          2,438.30         73.64      主要系本期利润总额增加所致
                                                                               本期公司生产效率提升、动物营养产
                                                                               品带来增量收益以及采购管理、销售
净利润             34,872.93    22,580.20         12,292.73         54.44      管理的提升带动公司毛利增加以及
                                                                               本期理财收益增加政府补贴增加带
                                                                               动净利润增加
现金流量表:                                                                                           单位:万元
项目               本报告期     上年同期           增减额      增减幅度%       差异说明
经营活动产生的现                                                               本期支付购买材料款增加以及支付
                   30,555.03    33,247.13         -2,692.11          -8.10
金流量净额                                                                     税费增加所致
投资活动产生的现                                                               主要系上期收回以前年度理财投资
                    -9,632.04    -2,012.51        -7,619.53         -378.61
金流量净额                                                                     款所致
筹资活动产生的现
                   -34,809.38   22,632.43         -57,441.80        -253.80    本期偿还到期融资款增加所致
金流量净额
                                                   5 / 17
                                   2017 年第一季度报告




3.2 重要事项进展情况及其影响和解决方案的分析说明

√适用 □不适用
    1.董事会换届选举
    因第七届董事会任期届满,经公司2017年第一次临时股东大会、第八届董事会第一次会议、
第八届监事会第一次会议审议通过,公司完成了换届选举,详见公司于2017年1月17日披露在上海
证券交易所网站上的相关公告。
    第八届董事会第一次会议选举王爱军为公司董事长,根据《公司章程》规定,董事长为公司
的法定代表人,目前法定代表人变更涉及到的工商登记手续尚在办理之中。为和现有营业执照保
持一致,本报告中涉及法定代表人均指原董事长孟庆山。
    2.员工持股计划的进展情况
    公司于2017年1月16日召开了2017年第一次临时股东大会,会上审议并通过了《梅花生物科技
集团股份有限公司2017年第一期员工持股计划(草案)及其摘要》(公告具体内容详见2017年1
月4日、2017年1月17日披露在《上海证券报》、《证券时报》及上海证券交易所网站的公告)。
    截至2017年1月26日,公司2017年第一期员工持股计划专户通过二级市场购买方式(竞价交易
方式)累计买入梅花生物股票29,007,028股,成交金额为人民币199,999,852.04元,成交均价约为
人民币6.895元/股,买入股票数量占公司总股本3,108,226,603股的0.93%。
    根据公司2017年第一次临时股东大会批准的方案,公司2017年第一期员工持股计划已完成购
买计划,购买的梅花生物股票将按照规定予以锁定,锁定期自2017年2月4日起12个月。
    3.2016年度利润分派实施情况
    2017年3月30日,公司发布了《2016年年度利润分派实施公告》,以2017年4月10日为股权登
记日,向全体股东每股分配现金红利0.3元(含税),共计派发现金红利932,467,980.90元(含税)。
截止本报告出具日,上述利润分派事项已实施完毕。
    4.投资入股辽宁艾美生物疫苗技术集团有限公司
    2017年3月17日,公司全资子公司拉萨梅花生物投资控股有限公司(以下简称“拉萨梅花”)与
辽宁艾美生物疫苗技术集团有限公司(简称“艾美生物”)签署了增资扩股协议,拉萨梅花货币出
资34,900万元投资入股艾美生物,投资完成后,拉萨梅花持有艾美生物6.3291%的股份,截止本报
告期末上述投资款项已支付完毕。



3.3 报告期内超期未履行完毕的承诺事项

□适用 √不适用


3.4 预测年初至下一报告期期末的累计净利润可能为亏损或者与上年同期相比发生重大变动的警
    示及原因说明

□适用 √不适用



                                         6 / 17
                                        2017 年第一季度报告



                                                   公司名称         梅花生物科技集团股份有限公司

                                                 法定代表人                   孟庆山

                                                       日期                  2017-4-19




四、 附录

4.1 财务报表

                                    合并资产负债表
                                   2017 年 3 月 31 日
编制单位:梅花生物科技集团股份有限公司
                                             单位:元 币种:人民币 审计类型:未经审计
                  项目                            期末余额                       年初余额
流动资产:
   货币资金                                             2,266,966,625.61            2,404,411,667.05
   结算备付金
   拆出资金
   以公允价值计量且其变动计入当期损益
的金融资产
   衍生金融资产
   应收票据                                              179,167,807.55                197,919,204.39
   应收账款                                              401,990,615.45                370,889,184.30
   预付款项                                              180,669,481.22                112,483,250.21
   应收保费
   应收分保账款
   应收分保合同准备金
   应收利息
   应收股利
   其他应收款                                            224,474,942.77                523,815,364.64
   买入返售金融资产
   存货                                                  899,969,449.76                832,885,913.58
   划分为持有待售的资产
   一年内到期的非流动资产
   其他流动资产                                          180,368,083.32                166,778,404.37
     流动资产合计                                       4,333,607,005.68            4,609,182,988.54
非流动资产:
   发放贷款和垫款
   可供出售金融资产                                      643,519,754.00                294,519,754.00
   持有至到期投资
   长期应收款
   长期股权投资
                                              7 / 17
                                        2017 年第一季度报告



   投资性房地产
   固定资产                                            10,606,873,978.27   10,911,145,082.38
   在建工程                                              186,812,557.84      130,322,328.06
   工程物资                                                 7,025,591.60        2,453,187.66
   固定资产清理
   生产性生物资产
   油气资产
   无形资产                                              774,948,850.62      783,523,043.45
   开发支出
   商誉                                                  143,173,700.39      143,173,700.39
   长期待摊费用                                           14,148,219.27       14,556,695.55
   递延所得税资产                                         14,426,682.28       13,905,040.91
   其他非流动资产                                         84,621,738.21       80,230,281.43
     非流动资产合计                                    12,475,551,072.48   12,373,829,113.83
       资产总计                                        16,809,158,078.16   16,983,012,102.37
流动负债:
   短期借款                                             2,092,663,000.00    1,555,915,457.87
   向中央银行借款
   吸收存款及同业存放
   拆入资金
   以公允价值计量且其变动计入当期损益
的金融负债
   衍生金融负债
   应付票据                                               22,100,000.00          100,000.00
   应付账款                                              546,236,477.44      503,748,813.98
   预收款项                                              247,807,478.92      377,588,983.15
   卖出回购金融资产款
   应付手续费及佣金
   应付职工薪酬                                           67,083,067.70       95,544,866.83
   应交税费                                              111,510,465.53      119,505,692.75
   应付利息                                               89,207,984.89       72,905,592.51
   应付股利                                                 9,665,014.72        9,665,014.72
   其他应付款                                            377,955,875.72      352,874,712.45
   应付分保账款
   保险合同准备金
   代理买卖证券款
   代理承销证券款
   划分为持有待售的负债
   一年内到期的非流动负债
   其他流动负债                                          499,649,482.49     1,498,939,893.45
     流动负债合计                                       4,063,878,847.41    4,586,789,027.71
非流动负债:

                                              8 / 17
                                   2017 年第一季度报告



   长期借款
   应付债券                                        2,987,794,275.85            2,986,745,297.71
   其中:优先股
          永续债
   长期应付款                                        20,000,000.00               20,000,000.00
   长期应付职工薪酬
   专项应付款
   预计负债
   递延收益                                          91,955,175.76               92,649,984.95
   递延所得税负债
   其他非流动负债
     非流动负债合计                                3,099,749,451.61            3,099,395,282.66
       负债合计                                    7,163,628,299.02            7,686,184,310.37
所有者权益
   股本                                            3,108,226,603.00            3,108,226,603.00
   其他权益工具
   其中:优先股
          永续债
   资本公积                                        2,242,451,490.53            2,242,451,490.53
   减:库存股
   其他综合收益
   专项储备
   盈余公积                                         362,759,728.12              362,759,728.12
   一般风险准备
   未分配利润                                      3,691,987,548.51            3,350,581,236.84
   归属于母公司所有者权益合计                      9,405,425,370.16            9,064,019,058.49
   少数股东权益                                     240,104,408.98              232,808,733.51
     所有者权益合计                                9,645,529,779.14            9,296,827,792.00
       负债和所有者权益总计                       16,809,158,078.16           16,983,012,102.37
法定代表人:孟庆山       主管会计工作负责人:李勇刚          会计机构负责人:王爱玲




                                         9 / 17
                                       2017 年第一季度报告



                                   母公司资产负债表
                                   2017 年 3 月 31 日
编制单位:梅花生物科技集团股份有限公司
                                               单位:元 币种:人民币 审计类型:未经审计
                     项目                              期末余额              年初余额
流动资产:
  货币资金                                               1,163,111,881.86       1,071,648,834.22
  以公允价值计量且其变动计入当期损益的金
融资产
  衍生金融资产
  应收票据                                                 131,850,446.50        135,333,041.93
  应收账款                                                 110,806,196.74        119,324,564.70
  预付款项                                                 207,756,613.34         72,896,691.87
  应收利息
  应收股利                                                                      1,000,000,000.00
  其他应收款                                             2,545,716,127.08       3,101,259,495.18
  存货                                                       73,036,422.26        34,455,728.17
  划分为持有待售的资产
  一年内到期的非流动资产
  其他流动资产                                               10,088,611.09        10,604,240.98
   流动资产合计                                          4,242,366,298.87       5,545,522,597.05
非流动资产:
  可供出售金融资产                                         260,519,754.00        260,519,754.00
  持有至到期投资
  长期应收款                                             3,211,987,200.41       3,178,163,222.26
  长期股权投资                                           5,546,575,394.00       5,546,575,394.00
  投资性房地产
  固定资产                                                 188,840,204.25        192,774,238.13
  在建工程
  工程物资
  固定资产清理
  生产性生物资产
  油气资产
  无形资产                                                   66,790,007.16        70,738,772.90
  开发支出
  商誉
  长期待摊费用                                               13,941,623.91        14,556,695.55
  递延所得税资产                                              3,706,449.34         3,706,449.34
  其他非流动资产
   非流动资产合计                                        9,292,360,633.07       9,267,034,526.18
     资产总计                                           13,534,726,931.94     14,812,557,123.23
流动负债:
  短期借款                                               1,370,000,000.00        830,190,557.87
  以公允价值计量且其变动计入当期损益的金
                                             10 / 17
                                      2017 年第一季度报告



融负债
  衍生金融负债
  应付票据                                                  30,000,000.00          200,000,000.00
  应付账款                                               192,378,386.03            955,046,073.78
  预收款项                                               156,901,091.39            274,738,822.09
  应付职工薪酬                                               5,733,769.09               9,811,170.43
  应交税费                                                   7,213,911.22              30,934,565.80
  应付利息                                                  85,706,561.12              69,950,449.18
  应付股利
  其他应付款                                           1,242,910,081.41           1,029,907,388.62
  划分为持有待售的负债
  一年内到期的非流动负债
  其他流动负债                                           499,649,482.49           1,498,939,893.45
   流动负债合计                                        3,590,493,282.75           4,899,518,921.22
非流动负债:
  长期借款
  应付债券                                             2,987,794,275.85           2,986,745,297.71
  其中:优先股
         永续债
  长期应付款
  长期应付职工薪酬
  专项应付款
  预计负债
  递延收益
  递延所得税负债
  其他非流动负债
   非流动负债合计                                      2,987,794,275.85           2,986,745,297.71
     负债合计                                          6,578,287,558.60           7,886,264,218.93
所有者权益:
  股本                                                 3,108,226,603.00           3,108,226,603.00
  其他权益工具
  其中:优先股
         永续债
  资本公积                                             2,208,701,622.94           2,208,701,622.94
  减:库存股
  其他综合收益
  专项储备
  盈余公积                                               362,759,728.12            362,759,728.12
  未分配利润                                           1,276,751,419.28           1,246,604,950.24
   所有者权益合计                                      6,956,439,373.34           6,926,292,904.30
     负债和所有者权益总计                             13,534,726,931.94          14,812,557,123.23


法定代表人:孟庆山          主管会计工作负责人:李勇刚        会计机构负责人:王爱玲

                                            11 / 17
                                         2017 年第一季度报告




                                             合并利润表
                                           2017 年 1—3 月
编制单位:梅花生物科技集团股份有限公司
                                                   单位:元 币种:人民币 审计类型:未经审计
                       项目                               本期金额                上期金额
一、营业总收入                                                 2,739,108,531.41    2,643,193,726.17
其中:营业收入                                                 2,739,108,531.41    2,643,193,726.17
      利息收入
      已赚保费
      手续费及佣金收入
二、营业总成本                                                 2,398,947,800.37    2,407,628,774.09
其中:营业成本                                                 1,948,799,189.30    2,004,913,897.04
      利息支出
      手续费及佣金支出
      退保金
      赔付支出净额
      提取保险合同准备金净额
      保单红利支出
      分保费用
      营业税金及附加                                             43,156,733.07         8,832,815.80
      销售费用                                                  238,826,069.15       189,589,780.07
      管理费用                                                  109,737,216.37       144,614,703.71
      财务费用                                                   58,428,592.48        59,677,577.47
      资产减值损失
  加:公允价值变动收益(损失以“-”号填列)
      投资收益(损失以“-”号填列)                             13,856,097.95         2,257,577.44
      其中:对联营企业和合营企业的投资收益                                            -1,084,976.78
      汇兑收益(损失以“-”号填列)
三、营业利润(亏损以“-”号填列)                              354,016,828.99       237,822,529.52
  加:营业外收入                                                 58,928,487.55        22,316,791.37
      其中:非流动资产处置利得                                      546,479.79               5,441.54
  减:营业外支出                                                  6,720,262.09         1,224,577.71
      其中:非流动资产处置损失                                      765,679.25          939,441.62
四、利润总额(亏损总额以“-”号填列)                          406,225,054.45       258,914,743.18
  减:所得税费用                                                 57,495,747.31        33,112,781.67
五、净利润(净亏损以“-”号填列)                              348,729,307.14       225,801,961.51
  归属于母公司所有者的净利润                                    341,433,631.67       221,744,194.40
  少数股东损益                                                    7,295,675.47         4,057,767.11
六、其他综合收益的税后净额
  归属母公司所有者的其他综合收益的税后净额
    (一)以后不能重分类进损益的其他综合收益

                                               12 / 17
                                            2017 年第一季度报告



       1.重新计量设定受益计划净负债或净资产的变

       2.权益法下在被投资单位不能重分类进损益的
其他综合收益中享有的份额
     (二)以后将重分类进损益的其他综合收益
       1.权益法下在被投资单位以后将重分类进损益
的其他综合收益中享有的份额
       2.可供出售金融资产公允价值变动损益
       3.持有至到期投资重分类为可供出售金融资产
损益
       4.现金流量套期损益的有效部分
       5.外币财务报表折算差额
       6.其他
  归属于少数股东的其他综合收益的税后净额
七、综合收益总额                                                   348,729,307.14       225,801,961.51
  归属于母公司所有者的综合收益总额                                 341,433,631.67       221,744,194.40
  归属于少数股东的综合收益总额                                       7,295,675.47         4,057,767.11
八、每股收益:
  (一)基本每股收益(元/股)                                                   0.11                0.07
  (二)稀释每股收益(元/股)                                                   0.11                0.07


本期发生同一控制下企业合并的,被合并方在合并前实现的净利润为:0 元,上期被合并方实现
的净利润为: 0 元。
法定代表人:孟庆山 主管会计工作负责人:李勇刚     会计机构负责人:王爱玲



                                     母公司利润表
                                    2017 年 1—3 月
编制单位:梅花生物科技集团股份有限公司
                                            单位:元 币种:人民币 审计类型:未经审计
                        项目                                 本期金额                上期金额
一、营业收入                                                      1,736,489,143.39    1,587,078,329.17
  减:营业成本                                                    1,521,076,163.79    1,441,583,000.14
       营业税金及附加                                                3,475,080.96         1,230,163.20
       销售费用                                                    158,284,895.49       117,745,493.69
       管理费用                                                     31,363,984.87        32,291,901.36
       财务费用                                                      1,135,139.34        -2,805,069.52
       资产减值损失
  加:公允价值变动收益(损失以“-”号填列)
       投资收益(损失以“-”号填列)                                8,678,884.01          706,751.25
       其中:对联营企业和合营企业的投资收益                                              -1,084,976.78
二、营业利润(亏损以“-”号填列)                                  29,832,762.95        -2,260,408.45
  加:营业外收入                                                       379,974.52          464,819.04
                                                  13 / 17
                                          2017 年第一季度报告



       其中:非流动资产处置利得
  减:营业外支出                                                       66,268.43               17,615.07
       其中:非流动资产处置损失                                         5,068.42                7,615.07
三、利润总额(亏损总额以“-”号填列)                             30,146,469.04            -1,813,204.48
     减:所得税费用
四、净利润(净亏损以“-”号填列)                                 30,146,469.04            -1,813,204.48
五、其他综合收益的税后净额
  (一)以后不能重分类进损益的其他综合收益
     1.重新计量设定受益计划净负债或净资产的变动
     2.权益法下在被投资单位不能重分类进损益的其他
综合收益中享有的份额
  (二)以后将重分类进损益的其他综合收益
     1.权益法下在被投资单位以后将重分类进损益的
其他综合收益中享有的份额
     2.可供出售金融资产公允价值变动损益
     3.持有至到期投资重分类为可供出售金融资产损

     4.现金流量套期损益的有效部分
     5.外币财务报表折算差额
     6.其他
六、综合收益总额                                                   30,146,469.04            -1,813,204.48
七、每股收益:
     (一)基本每股收益(元/股)
     (二)稀释每股收益(元/股)
法定代表人:孟庆山            主管会计工作负责人:李勇刚           会计机构负责人:王爱玲



                                  合并现金流量表
                                    2017 年 1—3 月
编制单位:梅花生物科技集团股份有限公司
                                            单位:元 币种:人民币 审计类型:未经审计
                      项目                                  本期金额                上期金额
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金                                2,691,587,772.04         2,289,478,547.97
  客户存款和同业存放款项净增加额
  向中央银行借款净增加额
  向其他金融机构拆入资金净增加额
  收到原保险合同保费取得的现金
  收到再保险业务现金净额
  保户储金及投资款净增加额
  处置以公允价值计量且其变动计入当期损益
的金融资产净增加额


                                                  14 / 17
                                       2017 年第一季度报告



  收取利息、手续费及佣金的现金
  拆入资金净增加额
  回购业务资金净增加额
  收到的税费返还                                                               45,696,921.78
  收到其他与经营活动有关的现金                               59,032,687.24     48,834,329.88
    经营活动现金流入小计                               2,750,620,459.28      2,384,009,799.63
  购买商品、接受劳务支付的现金                         1,734,747,190.57      1,315,589,773.38
  客户贷款及垫款净增加额
  存放中央银行和同业款项净增加额
  支付原保险合同赔付款项的现金
  支付利息、手续费及佣金的现金
  支付保单红利的现金
  支付给职工以及为职工支付的现金                         213,660,654.60       194,614,815.64
  支付的各项税费                                         242,859,120.07       155,759,331.05
  支付其他与经营活动有关的现金                           253,803,202.66       385,574,531.03
    经营活动现金流出小计                               2,445,070,167.90      2,051,538,451.10
      经营活动产生的现金流量净额                         305,550,291.38       332,471,348.53
二、投资活动产生的现金流量:
  收回投资收到的现金                                         17,000,000.00    566,900,000.00
  取得投资收益收到的现金                                     13,857,015.86      4,567,297.79
  处置固定资产、无形资产和其他长期资产收回                     150,000.00
的现金净额
  处置子公司及其他营业单位收到的现金净额                 300,000,000.00
  收到其他与投资活动有关的现金
    投资活动现金流入小计                                 331,007,015.86       571,467,297.79
  购建固定资产、无形资产和其他长期资产支付                   63,727,389.89     99,824,909.64
的现金
  投资支付的现金                                         363,600,000.00       491,767,473.00
  质押贷款净增加额
  取得子公司及其他营业单位支付的现金净额
  支付其他与投资活动有关的现金
    投资活动现金流出小计                                 427,327,389.89       591,592,382.64
      投资活动产生的现金流量净额                         -96,320,374.03        -20,125,084.85
三、筹资活动产生的现金流量:
  吸收投资收到的现金
  其中:子公司吸收少数股东投资收到的现金
  取得借款收到的现金                                     963,670,000.00       419,127,828.35
  发行债券收到的现金
  收到其他与筹资活动有关的现金                                                900,209,071.98
    筹资活动现金流入小计                                 963,670,000.00      1,319,336,900.33
  偿还债务支付的现金                                   1,268,556,000.00       689,356,749.43
  分配股利、利润或偿付利息支付的现金                         40,043,584.10     22,013,193.66

                                             15 / 17
                                       2017 年第一季度报告



  其中:子公司支付给少数股东的股利、利润
  支付其他与筹资活动有关的现金                                3,164,188.25            381,642,691.43
    筹资活动现金流出小计                                 1,311,763,772.35            1,093,012,634.52
      筹资活动产生的现金流量净额                          -348,093,772.35             226,324,265.81
四、汇率变动对现金及现金等价物的影响                         -1,745,374.69              -5,586,498.76
五、现金及现金等价物净增加额                              -140,609,229.69             533,084,030.73
  加:期初现金及现金等价物余额                           2,402,880,986.97             245,643,678.36
六、期末现金及现金等价物余额                             2,262,271,757.28             778,727,709.09
法定代表人:孟庆山         主管会计工作负责人:李勇刚             会计机构负责人:王爱玲



                                  母公司现金流量表
                                    2017 年 1—3 月
编制单位:梅花生物科技集团股份有限公司
                                            单位:元 币种:人民币 审计类型:未经审计
                   项目                                本期金额                   上期金额
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金                           1,645,111,913.92            1,320,945,664.21
  收到的税费返还
  收到其他与经营活动有关的现金                           1,519,899,298.10             689,861,932.77
    经营活动现金流入小计                                 3,165,011,212.02            2,010,807,596.98
  购买商品、接受劳务支付的现金                           2,251,487,541.48            1,057,859,576.96
  支付给职工以及为职工支付的现金                             23,859,371.61             16,421,235.74
  支付的各项税费                                             41,560,005.68             38,363,687.19
  支付其他与经营活动有关的现金                           1,575,713,901.72             472,367,838.94
    经营活动现金流出小计                                 3,892,620,820.49            1,585,012,338.83
      经营活动产生的现金流量净额                          -727,609,608.47             425,795,258.15
二、投资活动产生的现金流量:
  收回投资收到的现金                                                                  195,200,000.00
  取得投资收益收到的现金                                 1,008,678,884.01                  3,016,471.60
  处置固定资产、无形资产和其他长期资产收回
的现金净额
  处置子公司及其他营业单位收到的现金净额
  收到其他与投资活动有关的现金
    投资活动现金流入小计                                 1,008,678,884.01             198,216,471.60
  购建固定资产、无形资产和其他长期资产支付                         7,300.00            27,735,425.53
的现金
  投资支付的现金                                                                      502,969,972.76
  取得子公司及其他营业单位支付的现金净额
  支付其他与投资活动有关的现金
    投资活动现金流出小计                                           7,300.00           530,705,398.29
      投资活动产生的现金流量净额                         1,008,671,584.01            -332,488,926.69


                                             16 / 17
                                       2017 年第一季度报告



三、筹资活动产生的现金流量:
 吸收投资收到的现金
 取得借款收到的现金                                      570,000,000.00                289,000,000.00
 收到其他与筹资活动有关的现金                            278,000,000.00                400,000,000.00
   筹资活动现金流入小计                                  848,000,000.00                689,000,000.00
 偿还债务支付的现金                                    1,000,000,000.00                200,000,000.00
 分配股利、利润或偿付利息支付的现金                          37,598,927.66              14,483,506.26
 支付其他与筹资活动有关的现金                                  468,212.74              442,900,000.00
   筹资活动现金流出小计                                1,038,067,140.40                657,383,506.26
     筹资活动产生的现金流量净额                         -190,067,140.40                 31,616,493.74
四、汇率变动对现金及现金等价物的影响                                 -0.24                      -0.21
五、现金及现金等价物净增加额                                 90,994,834.90             124,922,824.99
 加:期初现金及现金等价物余额                          1,071,648,834.22                 77,736,675.89
六、期末现金及现金等价物余额                           1,162,643,669.12                202,659,500.88


法定代表人:孟庆山        主管会计工作负责人:李勇刚          会计机构负责人:王爱玲


4.2 审计报告

□适用 √不适用




                                             17 / 17
数据加载中...
prevnext
手机查看股票